CEN501

Allergic Rhinitis

PreclinicalActive

Key Facts

Indication

Allergic Rhinitis

Phase

Preclinical

Status

Active

Company

Taiwan biotech delivering nasal drug‑delivery platforms for allergy and oncology.

Drug	Company	Phase	Status
RYALTRIS®	Glenmark	Marketed	Commercialized; Direct U.S. Launch
Azelastine Hydrochloride	Coral Drugs	Commercial	Active
INI-2004	Inimmune	Phase 2	Active
Budesolv	Marinomed Biotech	Phase 2	Active